Controlling drug-to-antibody ratio and scalable reactors are key to reliable antibody-drug conjugate manufacturing success.

Khaberni - The end of the holy month of Ramadan represents an important milestone for the body, especially the liver, which ...

TOKYO, March 12, 2026 3 FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announces its investment in ...

AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ /6821.HK), recently announced that its Fengxian commercial ...

On National Vaccination Day, doctors highlight the importance of understanding India's National Immunization Schedule to protect children from preventable diseases. The schedule begins at birth and ...

JSKN021 is a “2-in-1” dual payload bispecific ADC targeting EGFR and HER3. By leveraging glycan-specific conjugation technology, it precisely and quantitatively links two different cytotoxic payloads ...

A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.

Radiopharmaceuticals are one of the most exciting frontiers in oncology and targeted therapies today. By combining biologically active molecules with radionuclides, radiopharmaceuticals can deliver ...

A team of chemists has demonstrated a way to form sulfur-sulfur bonds at room temperature without any external catalyst, ...

Over the next 5 years, Gland Pharma plans to invest approximately Rs 20 bn in capex, primarily towards BFS and ophthalmic ...

BioDlink, an innovation-driven Contract Development and Manufacturing Organization (CDMO), today announced that it has been named "Emerging CDMO of the Year" at the Asia-Pacific Biopharma Excellence ...

We have some tools to control bacteria, like antibiotics, but antibiotic resistance is a growing problem that is a threat to public health... | Microbiology ...